Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase.

Cancer cell | 2018

KRAS is a regulator of the nutrient stress response in non-small-cell lung cancer (NSCLC). Induction of the ATF4 pathway during nutrient depletion requires AKT and NRF2 downstream of KRAS. The tumor suppressor KEAP1 strongly influences the outcome of activation of this pathway during nutrient stress; loss of KEAP1 in KRAS mutant cells leads to apoptosis. Through ATF4 regulation, KRAS alters amino acid uptake and asparagine biosynthesis. The ATF4 target asparagine synthetase (ASNS) contributes to apoptotic suppression, protein biosynthesis, and mTORC1 activation. Inhibition of AKT suppressed ASNS expression and, combined with depletion of extracellular asparagine, decreased tumor growth. Therefore, KRAS is important for the cellular response to nutrient stress, and ASNS represents a promising therapeutic target in KRAS mutant NSCLC.

Pubmed ID: 29316436 RIS Download

Mesh terms: Activating Transcription Factor 4 | Animals | Asparaginase | Aspartate-Ammonia Ligase | Carcinoma, Non-Small-Cell Lung | Cell Line, Tumor | Homeostasis | Humans | Lung Neoplasms | Mice | Proto-Oncogene Proteins p21(ras)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.

The Cancer Genome Atlas (tool)


Project exploring the spectrum of genomic changes involved in more than 20 types of human cancer that provides a platform for researchers to search, download, and analyze data sets generated. As a pilot project it confirmed that an atlas of changes could be created for specific cancer types. It also showed that a national network of research and technology teams working on distinct but related projects could pool the results of their efforts, create an economy of scale and develop an infrastructure for making the data publicly accessible. Its success committed resources to collect and characterize more than 20 additional tumor types. Components of the TCGA Research Network: * Biospecimen Core Resource (BCR); Tissue samples are carefully cataloged, processed, checked for quality and stored, complete with important medical information about the patient. * Genome Characterization Centers (GCCs); Several technologies will be used to analyze genomic changes involved in cancer. The genomic changes that are identified will be further studied by the Genome Sequencing Centers. * Genome Sequencing Centers (GSCs); High-throughput Genome Sequencing Centers will identify the changes in DNA sequences that are associated with specific types of cancer. * Proteome Characterization Centers (PCCs); The centers, a component of NCI's Clinical Proteomic Tumor Analysis Consortium, will ascertain and analyze the total proteomic content of a subset of TCGA samples. * Data Coordinating Center (DCC); The information that is generated by TCGA will be centrally managed at the DCC and entered into the TCGA Data Portal and Cancer Genomics Hub as it becomes available. Centralization of data facilitates data transfer between the network and the research community, and makes data analysis more efficient. The DCC manages the TCGA Data Portal. * Cancer Genomics Hub (CGHub); Lower level sequence data will be deposited into a secure repository. This database stores cancer genome sequences and alignments. * Genome Data Analysis Centers (GDACs) - Immense amounts of data from array and second-generation sequencing technologies must be integrated across thousands of samples. These centers will provide novel informatics tools to the entire research community to facilitate broader use of TCGA data. TCGA is actively developing a network of collaborators who are able to provide samples that are collected retrospectively (tissues that had already been collected and stored) or prospectively (tissues that will be collected in the future).

View all literature mentions

cBioPortal (tool)


A portal that provides visualization, analysis and download of large-scale cancer genomics data sets.

View all literature mentions

ATF4-human antibody (antibody)


This unknown targets ATF4

View all literature mentions

Cleaved PARP (Asp214) (D64E10) XP Rabbit mAb antibody (antibody)


This monoclonal antibody targets Cleaved PARP (Asp214) (D64E10) XP Rabbit mAb

View all literature mentions

eIF2alpha (D7D3) XP Rabbit mAb antibody (antibody)


This monoclonal antibody targets eIF2alpha (D7D3) XP Rabbit mAb

View all literature mentions

Phospho-S6 Ribosomal Protein (Ser235/236) (D57.2.2E) XP Rabbit mAb antibody (antibody)


This monoclonal antibody targets Phospho-S6 Ribosomal Protein (Ser235/236) (D57.2.2E) XP Rabbit mAb

View all literature mentions

Asparagine synthetase (G-10) antibody (antibody)


This monoclonal antibody targets Asparagine synthetase (G-10)

View all literature mentions

Monoclonal Anti-beta-Actin antibody produced in mouse (antibody)


This monoclonal antibody targets beta-Actin antibody produced in mouse

View all literature mentions

GCN2 Antibody (antibody)


This unknown targets GCN2

View all literature mentions

Phospho-Akt (Ser473) antibody (antibody)


This monoclonal antibody targets Ser473

View all literature mentions

xCT/SLC7A11 (D2M7A) Rabbit Antibody (antibody)


This monoclonal antibody targets xCT/SLC7A11

View all literature mentions

4F2hc/CD98 (D6O3P) Rabbit Antibody (antibody)


This monoclonal antibody targets 4F2hc/CD98

View all literature mentions

ASCT2 (D7C12) Rabbit mAb antibody (antibody)


This monoclonal antibody targets ASCT2 (D7C12) Rabbit mAb

View all literature mentions

Akt Antibody (antibody)


This polyclonal antibody targets Akt

View all literature mentions

p44/42 MAPK (Erk1/2) (137F5) Rabbit mAb antibody (antibody)


This monoclonal antibody targets p44/42 MAPK (Erk1/2) (137F5) Rabbit mAb

View all literature mentions

Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) antibody (antibody)


This monoclonal antibody targets p44 / 42 MAPK, phospho (Thr202 / Tyr204)

View all literature mentions